Post market surveillance

News

Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.

Events

Partner Content

Deliver an Integrated Product Complaint System

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.